Work

Immune Checkpoint Inhibitors Plus Anlotinib Versus Anlotinib Alone as Third-Line Treatment in Advanced Non-Small-Cell Lung Cancer: A Retrospective Study

Year: 2021

Type: article

Study design: Observational Study

Source: Future Oncology

DOI: 10.2217/fon-2021-0649

Authors: Wenjie Zhang, Chufeng Zhang, Shengjie Yang, Qing Chen, Chen Wang, Qisen Guo

Institutions: Weifang Medical University, Shandong Tumor Hospital, Shandong First Medical University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Key Technology Research and Development Program of Shandong

OpenAlex ID: W3177626569

FWCI: 0.997

Cites: 29

Cited by: 10

Related to: 10